Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer

Identification of human cancer-reactive CD8+ T cells is crucial for the stratification of patients for immunotherapy and determination of immune-therapeutic effects. To date, these T cells have been identified mainly based on cell surface expression of programmed cell death protein 1 (PD-1) or co-ex...

Full description

Bibliographic Details
Main Authors: Joyce M. Lubbers, Marta A. Ważyńska, Nienke van Rooij, Arjan Kol, Hagma H. Workel, Annechien Plat, Sterre T. Paijens, Martijn R. Vlaming, Diana C. J. Spierings, Philip H. Elsinga, Edwin Bremer, Hans W. Nijman, Marco de Bruyn
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/8/1924
_version_ 1797436564364591104
author Joyce M. Lubbers
Marta A. Ważyńska
Nienke van Rooij
Arjan Kol
Hagma H. Workel
Annechien Plat
Sterre T. Paijens
Martijn R. Vlaming
Diana C. J. Spierings
Philip H. Elsinga
Edwin Bremer
Hans W. Nijman
Marco de Bruyn
author_facet Joyce M. Lubbers
Marta A. Ważyńska
Nienke van Rooij
Arjan Kol
Hagma H. Workel
Annechien Plat
Sterre T. Paijens
Martijn R. Vlaming
Diana C. J. Spierings
Philip H. Elsinga
Edwin Bremer
Hans W. Nijman
Marco de Bruyn
author_sort Joyce M. Lubbers
collection DOAJ
description Identification of human cancer-reactive CD8+ T cells is crucial for the stratification of patients for immunotherapy and determination of immune-therapeutic effects. To date, these T cells have been identified mainly based on cell surface expression of programmed cell death protein 1 (PD-1) or co-expression of CD103 and CD39. A small subset of CD103− CD39+ CD8+ T cells is also present in tumors, but little is known about these T cells. Here, we report that CD103− CD39+ CD8+ T cells from mismatch repair-deficient endometrial tumors are activated and characterized predominantly by expression of <i>TNFRSF9</i>. In vitro, transforming growth factor-beta (TGF-β) drives the disappearance of this subset, likely through the conversion of CD103− CD39+ cells to a CD103+ phenotype. On the transcriptomic level, T cell activation and induction of CD39 was associated with a number of tissue residence and TGF-β responsive transcription factors. Altogether, our data suggest CD39+ CD103− CD8+ tumor-infiltrating T cells are recently activated and likely rapidly differentiate towards tissue residence upon exposure to TGF-β in the tumor micro-environment, explaining their relative paucity in human tumors.
first_indexed 2024-03-09T11:03:32Z
format Article
id doaj.art-bb6741a5c186465885e60426cf214bbe
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T11:03:32Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-bb6741a5c186465885e60426cf214bbe2023-12-01T01:05:55ZengMDPI AGCancers2072-66942022-04-01148192410.3390/cancers14081924Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial CancerJoyce M. Lubbers0Marta A. Ważyńska1Nienke van Rooij2Arjan Kol3Hagma H. Workel4Annechien Plat5Sterre T. Paijens6Martijn R. Vlaming7Diana C. J. Spierings8Philip H. Elsinga9Edwin Bremer10Hans W. Nijman11Marco de Bruyn12Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsEuropean Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, 9713 AV Groningen, The NetherlandsDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Hematology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The NetherlandsIdentification of human cancer-reactive CD8+ T cells is crucial for the stratification of patients for immunotherapy and determination of immune-therapeutic effects. To date, these T cells have been identified mainly based on cell surface expression of programmed cell death protein 1 (PD-1) or co-expression of CD103 and CD39. A small subset of CD103− CD39+ CD8+ T cells is also present in tumors, but little is known about these T cells. Here, we report that CD103− CD39+ CD8+ T cells from mismatch repair-deficient endometrial tumors are activated and characterized predominantly by expression of <i>TNFRSF9</i>. In vitro, transforming growth factor-beta (TGF-β) drives the disappearance of this subset, likely through the conversion of CD103− CD39+ cells to a CD103+ phenotype. On the transcriptomic level, T cell activation and induction of CD39 was associated with a number of tissue residence and TGF-β responsive transcription factors. Altogether, our data suggest CD39+ CD103− CD8+ tumor-infiltrating T cells are recently activated and likely rapidly differentiate towards tissue residence upon exposure to TGF-β in the tumor micro-environment, explaining their relative paucity in human tumors.https://www.mdpi.com/2072-6694/14/8/1924CD103CD39PD-1TGF-βexhaustion
spellingShingle Joyce M. Lubbers
Marta A. Ważyńska
Nienke van Rooij
Arjan Kol
Hagma H. Workel
Annechien Plat
Sterre T. Paijens
Martijn R. Vlaming
Diana C. J. Spierings
Philip H. Elsinga
Edwin Bremer
Hans W. Nijman
Marco de Bruyn
Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
Cancers
CD103
CD39
PD-1
TGF-β
exhaustion
title Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
title_full Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
title_fullStr Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
title_full_unstemmed Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
title_short Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
title_sort expression of cd39 identifies activated intratumoral cd8 t cells in mismatch repair deficient endometrial cancer
topic CD103
CD39
PD-1
TGF-β
exhaustion
url https://www.mdpi.com/2072-6694/14/8/1924
work_keys_str_mv AT joycemlubbers expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT martaawazynska expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT nienkevanrooij expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT arjankol expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT hagmahworkel expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT annechienplat expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT sterretpaijens expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT martijnrvlaming expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT dianacjspierings expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT philiphelsinga expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT edwinbremer expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT hanswnijman expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer
AT marcodebruyn expressionofcd39identifiesactivatedintratumoralcd8tcellsinmismatchrepairdeficientendometrialcancer